Article

Segment 1 - Diagnosis and Prognosis of Multiple Myeloma

Moderator Michael Chernew, PhD, co-editor-in-chief, The American Journal of Managed Care, and professor, Leonard D. Schaeffer School of Healthcare Policy, Harvard, leads a panel discussion on multiple myeloma.

Moderator Michael Chernew, PhD, co-editor-in-chief, The American Journal of Managed Care, and professor, Leonard D. Schaeffer School of Healthcare Policy, Harvard, leads a panel discussion on multiple myeloma. He is joined by panel experts Jack Goldberg, MD, clinical professor of medicine and chief, Division of Hematology and Medical Oncology, Penn Presbyterian Medical Center; Shaji K. Kumar, MD, professor of medicine and consultant, Division of Hematology and Blood and Marrow Transplantation, Mayo Clinic; Gene Reeder, Rph, PhD, director, Managed Care Networks, Xcenda; and Anne Quinn Young, MPH, vice president of development and strategic partnerships, Multiple Myeloma Research Foundation (MMRF).

The panelists begin with a general discussion that focuses on the diagnosis and prognosis of multiple myeloma, including if early diagnosis is possible. Dr Kumar begins by analyzing whether there is evidence for familial myeloma.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
ASCO 2025
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Cathy Eng, MD, FACP, FASCO
Nini Wu, MD, Navista
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo